Copertina

Adjuvant chemotherapy in stage IB non-small cell lung carcinoma: A survival analysis

Fuente: Redalyc

Salvato in:

Dettagli Bibliografici
Autore principale:	D. Coutinho
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	Sociedade Portuguesa de Pneumologia 2016
Soggetti:	Medicina
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Endobronchial ultrasound-guided transbronchial needle aspiration for nodal staging in non-small cell lung carcinoma
di: D. Coutinho
Pubblicazione: (2017)

Routine characterization of biomarkers in non-small cell lung carcinoma: how much is enough?
di: José Carlos Machado
Pubblicazione: (2015)

Survival analysis of patients with non-small cell lung cancer treated by surgery with curative intent
di: C. Cruz
Pubblicazione: (2017)

Cell-free DNA in non-small cell lung cancer
di: Vaida Gedvilaitė
Pubblicazione: (2017)

Cost‐effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR‐mutated advanced non‐small cell lung cancer
di: Wentao Tian, et al.
Pubblicazione: (2024)

Overall survival according to time‐of‐day of immunochemotherapy for extensive‐stage small cell lung cancer
di: Zhe Huang, et al.
Pubblicazione: (2025)

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients
di: Chao Chen, et al.
Pubblicazione: (2026)

Impact of concurrent medications on the outcome of immunotherapy in non‐small cell lung carcinoma
di: Jun Yamada, et al.
Pubblicazione: (2024)

Boolean-network simplification and rule fitting to unravel chemotherapy resistance in non-small cell lung cancer
di: Espinoza, Alonso, et al.
Pubblicazione: (2025)

Efficacy of combined radiotherapy and chemotherapy versus radiotherapy for oral squamous cell carcinoma
di: Jaime Irisarri Arévalo
Pubblicazione: (2015)

The proportion of tumour stroma predicts response to treatment of immune checkpoint inhibitor in combination with chemotherapy in patients with stage IIIB−IV non‐small cell lung cancer
di: Lina Yi, et al.
Pubblicazione: (2024)

Comparison of survivals between sublobar resection and lobar resection for patients with clinical stage I non‐small cell lung cancer and interstitial lung disease: a propensity score matching analysis
di: Ryohei Matsushima, et al.
Pubblicazione: (2024)

PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines
di: Camille Huart, et al.
Pubblicazione: (2026)

Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non‐small‐cell lung cancer
di: Ayako Morita, et al.
Pubblicazione: (2024)

Treatment selection and real‐world analysis of immunotherapy with or without chemotherapy in PD‐L1‐high metastatic non‐small cell lung cancer
di: Samuel Smith, et al.
Pubblicazione: (2024)

Oral squamous cell carcinoma: survival, recurrence and death
di: Antônio Camilo de Souza-Cruz
Pubblicazione: (2014)

Immune checkpoint expression as prognostic biomarker candidates in non‐small cell lung carcinoma patients
di: Débora Maria Porto, et al.
Pubblicazione: (2024)

Is 18 F-FDG-PET/CT prognostic factor for survival in patients with small cell lung cancer? Single center experience
di: A. Inal
Pubblicazione: (2013)

Development and validation of nomogram for predicting the cancer‐specific survival among patients aged 80 and above with early‐stage non‐small cell lung cancer
di: Qiang Guo, et al.
Pubblicazione: (2024)

A two‐phase epigenome‐wide four‐way gene–smoking interaction study of overall survival for early‐stage non‐small cell lung cancer
di: Leyi Chen, et al.
Pubblicazione: (2024)

Can FDG‐PET after neoadjuvant chemotherapy plus nivolumab predict residual disease in non‐small cell lung cancer?
di: Hideto Iguchi, et al.
Pubblicazione: (2024)

Non-small cell lung cancer in young patients - A retrospective analysis of 10 years in a tertiary university hospital
di: R. Gomes
Pubblicazione: (2016)

Capivasertib augments chemotherapy via Akt inhibition in preclinical small cell lung cancer models
di: Cheng Long, et al.
Pubblicazione: (2024)

Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
di: Ali Inal
Pubblicazione: (2014)

CD81 promotes proliferation and predicts survival in lung squamous cell carcinoma
di: Ryu Kanzaki, et al.
Pubblicazione: (2026)

Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
di: Lin Lu, et al.
Pubblicazione: (2025)

Osimertinib prolongs progression‐free lung cancer survival after chemotherapy
di: Mike Fillon
Pubblicazione: (2024)

Increased opioid consumption in neoadjuvant immunotherapy plus chemotherapy for patients with non‐small‐cell lung cancer: A multicenter, prospective cohort study
di: Kaiyuan Wang, et al.
Pubblicazione: (2024)

Cost-effectiveness of pemetrexed in combination with cisplatin as first line treatment for patients with advanced non-squamous non-small-cell lung cancer in Spain
di: Jonathan González García
Pubblicazione: (2017)

Automated CT quantification of interstitial lung abnormality in patients with resectable stage I non‐small cell lung cancer: Prognostic significance
di: Jae Ho Chung, et al.
Pubblicazione: (2024)

Circulating levels of galectin‐9 are a potential biomarker of survival in advanced non‐small‐cell lung cancer
di: Guilherme Vieira de Mendonça Filho, et al.
Pubblicazione: (2024)

Efficacy and safety of novel immune checkpoint inhibitor‐based combinations versus chemotherapy as first‐line treatment for patients with extensive‐stage small cell lung cancer: A network meta‐analysis
di: Chuang Yang, et al.
Pubblicazione: (2024)

Clinical outcomes for neoadjuvant immunochemotherapy or chemotherapy versus concurrent chemoradiotherapy in limited‐stage small‐cell lung cancer: A retrospective, multi‐center, real‐world study
di: Zichen Zhao, et al.
Pubblicazione: (2025)

Single‐cell transcriptome analysis reveals heterogeneity of neutrophils in non‐small cell lung cancer
di: Yunzhen Wang, et al.
Pubblicazione: (2024)

Sudden onset acute liver failure in a patient with clinically occult small cell lung carcinoma: autopsy report and review of the medical literature
di: Massimiliano Guerriero
Pubblicazione: (2019)

Is wedge resection equivalent to segmentectomy in pathological stage IA (≤2 cm) non‐small cell lung cancers?
di: Zhirong Zhang, et al.
Pubblicazione: (2024)

Optimizing management of stage IV EGFR mutant non‐small cell lung cancer in Asia: An expert opinion
di: Gee‐Chen Chang, et al.
Pubblicazione: (2025)

Establishment, culture and characterization of gemcitabine hydrochloride‐resistant human non‐small cell lung carcinoma cell line derived cancer stem cells
di: Bahar Demir Cevizlidere, et al.
Pubblicazione: (2024)

Occipital condyle syndrome due to small‐cell lung carcinoma: A case report
di: Satoshi Yamashita, et al.
Pubblicazione: (2024)

Review of patient‐reported outcomes in EMPOWER‐Lung 1 in patients with advanced non‐small cell lung cancer treated with cemiplimab versus chemotherapy
di: David R. Gandara, et al.
Pubblicazione: (2026)